Arrowhead Pharmaceuticals Announces Closing of Global License and Collaboration Agreement with Novartis Biotech Investing
Cardiol Therapeutics Completes US$11.4 Million Financing and Extends Cash Runway into Q3 2027 Biotech Investing
Clearmind Medicine Enrolls Last Patient for the First Cohort of its FDA-Approved Phase I/IIa Clinical Trial for Alcohol Use Disorder Biotech Investing
SynOx Therapeutics Strengthens Board of Directors with Leading Experts in Commercialisation and Corporate Development Amid Continued Corporate Progress Biotech Investing
Sionna Therapeutics Announces Initiation of PreciSION CF Phase 2a Trial Evaluating NBD1 Stabilizer, SION-719, When Added to Standard of Care in Participants with Cystic Fibrosis Biotech Investing
LYVDELZI® RECEIVES HEALTH CANADA APPROVAL FOR THE TREATMENT OF PRIMARY BILIARY CHOLANGITIS Pharmaceutical Investing
Climb Bio Names Adam Villa as SVP, Technical Operations and Ashley Jones as SVP, People & Workforce Strategy Biotech Investing
